Adaptimmune Therapeutics
ADAP
#9421
Rank
$57.64 M
Marketcap
$0.22
Share price
-12.60%
Change (1 day)
-83.52%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Adaptimmune Therapeutics CIK: 0001621227

Thumbnail Adaptimmune Therapeutics 20-F Annual Report

20-F Annual Report 2016-03-17

Language: English

View Annual Report (20-F)
Thumbnail Adaptimmune Therapeutics 20-F Annual Report

20-F Annual Report 2015-10-13

Language: English

View Annual Report (20-F)